These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ. Am J Cardiol; 2008 Dec 01; 102(11):1427-32. PubMed ID: 19026290 [Abstract] [Full Text] [Related]
14. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN. Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357 [Abstract] [Full Text] [Related]
18. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. Manolis AS, Uricchio F, Estes NA. Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375 [Abstract] [Full Text] [Related]
19. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME, TIMI Study Group. J Am Coll Cardiol; 2008 Feb 05; 51(5):546-51. PubMed ID: 18237683 [Abstract] [Full Text] [Related]